Kala Bio Inc (KALA)
6.82
+0.04
(+0.60%)
USD |
NASDAQ |
Nov 05, 11:48
Kala Bio Market Cap: 31.42M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 31.24M |
| November 01, 2024 | 32.21M |
| October 31, 2024 | 32.44M |
| October 30, 2024 | 31.56M |
| October 29, 2024 | 33.13M |
| October 28, 2024 | 33.13M |
| October 25, 2024 | 31.33M |
| October 24, 2024 | 30.18M |
| October 23, 2024 | 27.88M |
| October 22, 2024 | 25.48M |
| October 21, 2024 | 24.14M |
| October 18, 2024 | 23.96M |
| October 17, 2024 | 23.55M |
| October 16, 2024 | 24.24M |
| October 15, 2024 | 23.96M |
| October 14, 2024 | 23.82M |
| October 11, 2024 | 24.28M |
| October 10, 2024 | 24.24M |
| October 09, 2024 | 24.07M |
| October 08, 2024 | 24.47M |
| October 07, 2024 | 24.65M |
| October 04, 2024 | 24.88M |
| October 03, 2024 | 24.42M |
| October 02, 2024 | 24.84M |
| October 01, 2024 | 25.25M |
| Date | Value |
|---|---|
| September 30, 2024 | 26.26M |
| September 27, 2024 | 24.65M |
| September 26, 2024 | 24.19M |
| September 25, 2024 | 25.16M |
| September 24, 2024 | 25.43M |
| September 23, 2024 | 26.17M |
| September 20, 2024 | 26.68M |
| September 19, 2024 | 26.72M |
| September 18, 2024 | 26.72M |
| September 17, 2024 | 26.49M |
| September 16, 2024 | 26.54M |
| September 13, 2024 | 27.23M |
| September 12, 2024 | 27.42M |
| September 11, 2024 | 27.74M |
| September 10, 2024 | 27.23M |
| September 09, 2024 | 27.42M |
| September 06, 2024 | 27.65M |
| September 05, 2024 | 26.95M |
| September 04, 2024 | 27.74M |
| September 03, 2024 | 27.14M |
| August 30, 2024 | 26.95M |
| August 29, 2024 | 27.14M |
| August 28, 2024 | 27.18M |
| August 27, 2024 | 27.92M |
| August 26, 2024 | 28.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.854M
Minimum
Dec 22 2022
768.31M
Maximum
Jun 02 2020
174.77M
Average
49.61M
Median
Feb 24 2022
Market Cap Benchmarks
| CEL-SCI Corp | 49.74M |
| AIM ImmunoTech Inc | 15.67M |
| IGC Pharma Inc | 29.27M |
| NovaBay Pharmaceuticals Inc | 3.762M |
| Protalix BioTherapeutics Inc | 94.87M |
Market Cap Related Metrics
| PS Ratio | 3.295 |
| Price to Book Value | 2.291 |
| Price | 6.82 |
| Earnings Yield | -204.5% |